Liraglutide has also been shown to significantly reduce the incidence of prostate cancer and improve survival outcomes in diabetic patients diagnosed with prostate cancer [36, 37]
It is also important to note that early-phase trials such as those conducted for retatrutide typically exclude participants with active major depressive disorder or suicidal ideation, which may limit the detection of psychiatric adverse events in the published data
You may be a good candidate for GLP-1 treatment if you: Have been diagnosed with type 2 diabetes Have obesity, or a body mass index (BMI) of 30 or higher Have overweight (a BMI of 25 to 29.9) plus at least one weight-related condition, such as heart disease or type 2 diabetes Ultimately, the decision to start treatment for weight loss is up to you and your healthcare provider
Kim YJ, Park EJ, Lee SH, Silwal P, Kim JK, Yang JS, Whang J, Jang J, Kim JM, Jo EK
Your chart becomes unreliable if your medication has lost potency
However, the experts we spoke to do not recommend them